NCT03301532View on ClinicalTrials.gov

Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 5, 2018

Primary Completion Date

June 18, 2021

Study Completion Date

July 31, 2022

Conditions
GLUT1DS1
Interventions
DRUG

Triheptanoin

Dietary supplementation with triheptanoin

Trial Locations (1)

75390

UTexasSouthwestern, Dallas

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Texas Southwestern Medical Center

OTHER

NCT03301532 - Compatibility of C7 With Ketogenic Diet in Patients Diagnosed With G1D | Biotech Hunter | Biotech Hunter